rVSV∆G-MARV-GP | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,949 results for “rVSV∆G-MARV-GP”

Trials

View all 2573 →

A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

112 participants · First posted Feb 23, 2026

Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects

36 participants · First posted Feb 20, 2024

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP Vaccine)

248 participants · First posted Jun 2, 2016

Drugs

View all 1043 →

rVSV∆G-MARV-GP(International AIDS Vaccine Initiative)

rVSV-delta-G-MARV-GP vaccine

rVSV-delta-G-SUDV-GPC vaccine

Organizations

View all 114 →

GP PHARM SA

Spain

G&G MEDICAL INC

United States

G-MARK PTY LIMITED

Australia

News

View all 1219 →

IAVI Initiates First-in-Human Trial of Single-Dose Marburg Virus Vaccine Candidate

Breakthrough Antibody MARV16 Shows 40-100 Fold Increased Potency Against Marburg Virus

Midlothian GP Practice Champions Clinical Research in Long COVID Trial

Page 1 of 495